Shares of Express Scripts ESRX have jumped 5.52% to $104.56 in today's trading session. The activity in the stock coincides with news that Walgreen Co. WAG is ending its new pharmacy-benefit-management business with CVS Caremark CVS. According to analysts, this news could benefit other PBMs such as Express Scripts (ESRX), which administers prescription drug programs for health plans, government and corporations, by opening up new contracts. The company is projected to report $40 billion in revenue for 2010.
ESRX has been a very strong stock, gaining nearly 21% year-to-date. The growth story at the company appears to be firmly on track. Last week, ESRX opened its new $60 million pharmacy automation center. The shares are trading at a forward P/E ratio of 16.56 and a PEG ratio of 1.01. The company currently has a market cap of $28.65 billion.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in